Proteon Therapeutics Garners $15,183,371 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c5db6c2-71b6-4919-930e-2cd613866a3a&Preview=1 - Date
8/12/2011 - Company Name
Proteon Therapeutics - Mailing Address
200 West Street Waltham, MA 02451 - Company Description
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. - Website
http://www.proteontherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$15,183,371 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
